Having trouble viewing this email?View the content as a web page.

HSE Biocides ebulletin

Issued: 6 October 2023

This ebulletin contains informationonregulating biocides in Northern Ireland (NI).

The EU Biocidal Products Regulation (EU BPR) operates independently from the GB Biocidal Products Regulation (GB BPR), which applies in Great Britain.

Separate ebulletins containing information specific to regulating biocides in GB are issued as appropriate.

Northern Ireland Retail Movement Scheme

Impact on biocidal products and treated articles

The Windsor Framework establishes a new way to move pre-packed retail goods from Great Britain (England, Scotland and Wales) into Northern Ireland. It is called the Northern Ireland Retail Movement Scheme.

GB public health and consumer protection standards apply for all products moving to Northern Ireland through the scheme. This includes requirements for food contact materials.

Biocidal products and treated articles may come into scope of the Northern Ireland Retail Movement Scheme if they meet definition of a food contact material.

Find out more about the scheme.

Upcoming EU active substance open invitation deadlines

Submit a notification by the deadline to keep active substances in the EU Review Programme

The European Chemicals Agency (ECHA) has published open invitationsto provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the EU Review Programme for the following active substance/product type combinations.This affects NI.

Anyone wishing to support one of the active substance/product type combinations listed below in the EU will need to submit a notification to ECHA by the following deadline:

If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to an EU non-approval decision. Biocidal products containing active substances with EU non-approval decisions for the relevant product types will have to be removed from the NI market. HSE will provide separate updates on these where relevant.

If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, pleasecontact us.